Continuous subcutaneous waking day apomorphine in the long-term treatment of levodopa induced interdose dyskinesias in Parkinson's disease. - Colzi,A.; Turner,K.; Lees,A.J. (J Neurol Neurosurg Psychiatr, 1998)